ELECTROLYTE IMBALANCES IN PATIENTS ADMITTED WITH CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA: PATTERNS AND IMPACT ON OUTCOMES. A SINGLE CENTER STUDY FROM PAKISTAN

被引：0
|
作者：
Bawany, Samira Ahmad
机构：
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：636 / 636
页数：1
相关论文
共 50 条
  • [21] Assessment of chemotherapy induced febrile neutropenia in cancer patients: A prospective observational study in South India
    Mateti, U. V.
    Sebastian, A. M.
    Philip, M. L.
    Saj, N.
    Shetty, V.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study
    Tomomatsu, Takuya
    Shimizu, Hisanori
    Yokokawa, Takashi
    Fukada, Ippei
    Kawakami, Kazuyoshi
    Kobayashi, Kazuo
    Aoyama, Takeshi
    Suzuki, Wataru
    Sugisaki, Takahito
    Hashimoto, Koki
    Asano, Maimi
    Mori, Yuka
    Hara, Fumikata
    Takano, Toshimi
    Ohno, Shinji
    Yamaguchi, Masakazu
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2024, 144 (09): : 897 - 904
  • [23] EPIDEMIOLOGY AND OUTCOMES OF PATIENTS WITH INJURIES ADMITTED TO THE PICU: A SINGLE-CENTER STUDY
    Bricklin, Laura
    Reddy, Anireddy
    Zonfrillo, Mark
    Traynor, Danielle
    Winston, Flaura
    Woods-Hill, Charlotte
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [24] MONITOR-GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy-induced/febrile neutropenia prophylaxis
    Gascon, Pere
    Krendyukov, Andriy
    Hoebel, Nadja
    Aapro, Matti
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (03) : 241 - 246
  • [25] The Impact of 25(OH)Vitamin D Level on Outcome in Pediatric Patients with Chemotherapy-Induced Febrile Neutropenia
    Genc, D.
    Gok, T.
    Vural, S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S342 - S343
  • [26] Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in 2489 cancer patients: final results from the non-interventional study NADIR
    Fietz, Thomas
    Lueck, Andreas
    Schulz, Holger
    Harde, Johanna
    Losem, Christoph
    Grebhardt, Sina
    Wolff, Thomas
    Potthoff, Karin
    Mueller, Udo
    Zaiss, Matthias
    Kurbacher, Christian Martin
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (07) : 1127 - 1138
  • [27] Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study)
    Aapro, Matti
    Bokemeyer, Carsten
    Ludwig, Heinz
    Gascon, Pere
    Boccadoro, Mario
    Denhaerynck, Kris
    Gorray, Michael
    Krendyukov, Andriy
    MacDonald, Karen
    Abraham, Ivo
    JOURNAL OF GERIATRIC ONCOLOGY, 2017, 8 (02) : 86 - 95
  • [28] Clinical Predictive Models for Chemotherapy-Induced Febrile Neutropenia in Breast Cancer Patients: A Validation Study
    Chen, Kai
    Zhang, Xiaolan
    Deng, Heran
    Zhu, Liling
    Su, Fengxi
    Jia, Weijuan
    Deng, Xiaogeng
    PLOS ONE, 2014, 9 (06):
  • [29] Clinical predictive models for chemotherapy-induced febrile neutropenia in breast cancer patients: A validation study
    Chen, Kai
    Zhang, Xiaolan
    Zhu, Liling
    Su, Fengxi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Hospitalizations for Chemotherapy-Induced Febrile Neutropenia in Patients With Lung Cancer in France From 2017 to 2020
    Densari, Z.
    Desamencq, G.
    Thome, B.
    Freyer, G.
    VALUE IN HEALTH, 2022, 25 (12) : S215 - S216
12345